Subscribe
Acessa Health, a Uterine Fibroids FemTech Exit – Episode 72

FemTech Focus

Acessa Health, a Uterine Fibroids FemTech Exit – Episode 72

Kim Rodriguez was the President, CEO and Co-Founder of Acessa Health, Inc. who successfully sold to Hologic. Prior to Acessa Health, she served as president & CEO of Halt Medical.…
December 16, 2020
ADVERTISEMENT
TransferWise

Acessa Health, a Uterine Fibroids FemTech Exit – Episode 72

Kim Rodriguez was the President, CEO and Co-Founder of Acessa Health, Inc. who successfully sold to Hologic. Prior to Acessa Health, she served as president & CEO of Halt Medical. Prior to that, senior vice president of the Vascular Intervention business unit at Spectranetics, a publicly-traded cardiovascular company acquired by Royal Philips for $2.2B. Over the course of a 20+ year career in cardiology, radiology, vascular surgery, neurology and women’s health, Kim has been involved in the commercialization of dozens of innovative medtech technologies and M&A transactions. Kim received her Executive MBA at the University of Southern California Marshall School of Business and B.S. in Management from Pepperdine University. We discussed being a FemTech exit, uterine fibroids and hysterectomies.

Check out the Acessa Health at www.acessaprocedure.com
Rate, Review & Subscribe!

ADVERTISEMENT
TransferWise

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

Top Health Podcasts. Delivered to Your Inbox and Eardrums.

Proudly supported by:

cover
Hera Diagnostics is eradicating cervical cancer in developing communities Teo Tijerina is the CEO of Hera Medical Devices, a cancer diagnostics startup currently focusing on bringing a cervical cancer screening tool to market.